Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Revenues	$ 5,017	$ 4,347	$ 13,580	$ 13,389
Cost of revenues	921	1,136	2,644	3,566
Gross profit	4,096	3,211	10,936	9,823
Operating expenses:
Selling and marketing	1,053	1,478	3,763	4,787
Research and development	1,608	2,603	4,824	8,213
General and administrative	1,700	2,268	5,812	7,660
Depreciation and amortization	1,197	1,347	3,741	4,045
Gain on sale of assets, net	0	0	0	(1,287)
Goodwill impairment	0	0	0	11,052
Total operating expenses	5,558	7,696	18,140	34,470
Operating loss	(1,462)	(4,485)	(7,204)	(24,647)
Other income (expense):
Change in fair value of warrant liabilities	10	34	1	137
Interest expense, net	(243)	(66)	(990)	(114)
Other expense, net	(3)	(18)	(51)	(149)
Loss before provision for income tax	(1,698)	(4,535)	(8,244)	(24,773)
Provision for income tax expense	0	0	0	1
Net loss	(1,698)	(4,535)	(8,244)	(24,774)
Deemed dividend	0	(635)	(86)	(635)
Net loss attributable to common stockholders	$ (1,698)	$ (5,170)	$ (8,330)	$ (25,409)
Net loss per share attributable to common stockholders – basic and diluted
Basic (in dollars per share)	$ (0.3)	$ (1.23)	$ (1.57)	$ (6.5)
Weighted average shares outstanding:
Weighted average shares outstanding – basic (in shares)	5,588	4,195	5,315	3,909